Phthalate Chemicals Banned from Children’s Toys by CPSC

Federal health officials have voted in favor of banning certain harmful phthalate chemicals used during the production of vinyl and soft plastic children’s toys, which have been linked to adverse health consequences.

The U.S. Consumer Product Safety Commission (CPSC) announced a phthalate ban last week, after officials voted 3-2 in favor of prohibiting children’s toys and child care products from containing more than 0.1 percent of certain phthalate chemicals that may expose children to dangerous side effects.

Based on the recommendations from the Chronic Hazard Advisory Panel (CHAP), the CPSC ruled on October 18, 2017 that an additional five phthalate chemicals should be banned from children’s toys and child care products.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The CPSC and CHAP have been working towards banning additional phthalate chemicals from children’s products, as recent studies have found exposure of the chemicals to children can result in short term and long term adverse health consequences.

In 2008, Congress permanently prohibited children’s toys and child care articles from containing concentrations of more than 0.1 percent of three phthalates, when they passed the Consumer Product Safety Improvement Act of 2008 (CPSIA).

Previously banned phthalate chemicals under the ACT were di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and benzyl butyl phthalate (BBP). The newest ruling also bans concentrations of more than 0.1 in child products for diisononyl phthalate (DINP),di-n-pentyl phthalate (DPENP), di-n-hexyl phthalate (DHEXP), dicyclohexyl phthalate (DCHP) and diisobutyl phthalate (DIBP).

Phthalates are a class of industrial compounds commonly known as plasticizers. The chemicals are often used to make plastic more flexible or to help cosmetics slide on more smoothly.

In addition to toys, phthalates are found in food packaging, detergents, textiles, plastic tubing used in hospitals to deliver medications, the coatings on pills, including some aspirin, and many other products. They are known endocrine disruptors, which interfere with the natural way the body regulates and produces hormones. Studies have found phthalates may contribute to a slew of side effects, including birth defects, cancer, diabetes and infertility.

A study released in March by CHAP concluded that phthalate exposure can lead to reduced anogenital distance (AGD) in boys and other sexual developmental problems. As a result, the panel recommends that many iterations of the chemical should be permanently banned from children’s toys.

Previous studies, such as a study published in Environmental Health Perspectives in 2011 found phthalates interfere with the proper functioning of the thyroid and can result in a decrease in thyroid hormones by 10 percent following high exposure to the chemical.

The rules will apply to children’s toys which are defined by the CPSIA as products designed or intended by the manufacturer for play by a child 12 years of age or younger, and child care articles which are defined as consumer products intended or manufactured to help facilitate sleep or the feeding of children age three and younger, or to help children sucking or teething.

The new rule is set to be finalized and will take effect 180 days after publication in the Federal Register, in which all manufactures will be obligated to comply with the new standards.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted today)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted today)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 3 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.